Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus.
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, Yan B, Jiang Q. · 2014
Read Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. by Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, Yan B, Jiang Q. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4649539.txt.
Description
Jian-Ying Liu and colleagues published a 2014 study on MALAT1, a long non-coding RNA, in diabetic eye disease. Their earlier work tied MALAT1 misregulation to diabetic retinopathy, where retinal blood vessels decay. This study asked how the RNA harms the vessel lining. Tests used diabetic rats and mice plus cultured retinal cells. The work appeared in Cell Death and Disease.
MALAT1 levels rose sharply in diabetic retinas. Silencing it in animals reduced pericyte loss, capillary decay, leakage, and inflammation. In cells it also controlled growth, movement, and tube formation. Crosstalk with the p38 MAPK signalling pathway carried part of the effect. Because blocking MALAT1 protected vessels, the authors propose it as a target for treating diabetes-related microvascular complications.
Catalog record
| CREATOR | Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, Yan B, Jiang Q. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |